Cabozantinib with nivolumab

Status:: Red
Decision Date:: April 2024

Comments

SSC2626: for untreated advanced renal cell carcinoma. NHSE commissioned.

Red Drug Classifications

8. NHS England commissioned – to be used in line with NHSE commissioning intentions